眼科指南

订阅

MedSci主页 / 所有栏目 / 眼科指南

眼内液病毒核酸检测流程及临床规范化应用专家共识

2021-12-28 中国医学装备协会眼科专业委员会 解放军医学杂志

眼内液病毒核酸检测

病毒是常见的眼内感染病原体之一。对疑诊为眼内病毒性感染的患者进行眼内液病毒核酸检测已成为明确病因的重要手段。

中文标题：

眼内液病毒核酸检测流程及临床规范化应用专家共识

发布机构：

中国医学装备协会眼科专业委员会

发布日期：

2021-12-28

简要介绍：

病毒是常见的眼内感染病原体之一。对疑诊为眼内病毒性感染的患者进行眼内液病毒核酸检测已成为明确病因的重要手段。同时，确诊为眼内病毒性感染的患者进行眼内液病毒核酸检测，对调整后续治疗方案、判断治疗终点、预测治疗效果等具有重要意义。标准化的眼内液标本采集与实验室病毒核酸检测流程是确保检测结果稳定、可靠、有效的前提。鉴于此，中国医学装备协会眼科专业委员会眼科检验检测学组与中国中西医结合学会检验医学专业委员会眼科疾病实验诊断专家委员会的专家共同制定了《眼内液病毒核酸检测流程及临床规范化应用专家共识》，包括实验室建设标准、具体检测流程、标准化质量控制体系以及临床应用价值等方面，以期促进眼内液病毒核酸检测的规范化与标准化进程，助力眼内病毒性感染相关疾病的精准诊断与治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=眼内液病毒核酸检测流程及临床规范化应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0afd81c0023139ca, title=眼内液病毒核酸检测流程及临床规范化应用专家共识, enTitle=, guiderFrom=解放军医学杂志, authorId=0, author=, summary=病毒是常见的眼内感染病原体之一。对疑诊为眼内病毒性感染的患者进行眼内液病毒核酸检测已成为明确病因的重要手段。, cover=https://img.medsci.cn/202216/1641448775522_5579292.png, journalId=0, articlesId=null, associationId=1765, associationName=中国医学装备协会眼科专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Dec 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">病毒是常见的眼内感染病原体之一。对疑诊为眼内病毒性感染的患者进行眼内液病毒核酸检测已成为明确病因的重要手段。同时，确诊为眼内病毒性感染的患者进行眼内液病毒核酸检测，对调整后续治疗方案、判断治疗终点、预测治疗效果等具有重要意义。标准化的眼内液标本采集与实验室病毒核酸检测流程是确保检测结果稳定、可靠、有效的前提。鉴于此，中国医学装备协会眼科专业委员会眼科检验检测学组与中国中西医结合学会检验医学专业委员会眼科疾病实验诊断专家委员会的专家共同制定了《眼内液病毒核酸检测流程及临床规范化应用专家共识》，包括实验室建设标准、具体检测流程、标准化质量控制体系以及临床应用价值等方面，以期促进眼内液病毒核酸检测的规范化与标准化进程，助力眼内病毒性感染相关疾病的精准诊断与治疗。</span></p>, tagList=[TagDto(tagId=120959, tagName=眼内液病毒核酸检测)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9247, appHits=93, showAppHits=0, pcHits=593, showPcHits=9154, likes=0, shares=18, comments=8, approvalStatus=1, publishedTime=Thu Jan 06 13:56:57 CST 2022, publishedTimeString=2021-12-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Jan 06 14:00:26 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 08:03:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=眼内液病毒核酸检测流程及临床规范化应用专家共识.pdf)])
眼内液病毒核酸检测流程及临床规范化应用专家共识.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206298, encodeId=f0aa120629838, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Sun Mar 27 09:50:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184938, encodeId=d74d118493825, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Sun Jan 16 20:19:00 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182424, encodeId=c29b118242498, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:23:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182080, encodeId=bde2118208077, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 08 07:25:08 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181942, encodeId=a81111819426a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ebd6453870, createdName=ms9000000396022477, createdTime=Fri Jan 07 18:50:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-03-27 MaYazhen

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206298, encodeId=f0aa120629838, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Sun Mar 27 09:50:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184938, encodeId=d74d118493825, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Sun Jan 16 20:19:00 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182424, encodeId=c29b118242498, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:23:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182080, encodeId=bde2118208077, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 08 07:25:08 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181942, encodeId=a81111819426a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ebd6453870, createdName=ms9000000396022477, createdTime=Fri Jan 07 18:50:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-16 245462683

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206298, encodeId=f0aa120629838, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Sun Mar 27 09:50:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184938, encodeId=d74d118493825, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Sun Jan 16 20:19:00 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182424, encodeId=c29b118242498, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:23:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182080, encodeId=bde2118208077, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 08 07:25:08 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181942, encodeId=a81111819426a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ebd6453870, createdName=ms9000000396022477, createdTime=Fri Jan 07 18:50:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-09 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206298, encodeId=f0aa120629838, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Sun Mar 27 09:50:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184938, encodeId=d74d118493825, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Sun Jan 16 20:19:00 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182424, encodeId=c29b118242498, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:23:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182080, encodeId=bde2118208077, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 08 07:25:08 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181942, encodeId=a81111819426a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ebd6453870, createdName=ms9000000396022477, createdTime=Fri Jan 07 18:50:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-08 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1206298, encodeId=f0aa120629838, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Sun Mar 27 09:50:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184938, encodeId=d74d118493825, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Sun Jan 16 20:19:00 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182424, encodeId=c29b118242498, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Jan 09 07:23:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182080, encodeId=bde2118208077, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 08 07:25:08 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181942, encodeId=a81111819426a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ebd6453870, createdName=ms9000000396022477, createdTime=Fri Jan 07 18:50:06 CST 2022, time=2022-01-07, status=1, ipAttribution=)]
    2022-01-07 ms9000000396022477

    学习了

    0